Post-infection gut dysbiosis drives systemic inflammation, leaky gut, and immune dysregulation all of which amplify fatigue, cognitive impairment, and mood instability.3 BPC-157 has been shown in multiple animal studies to: Accelerate healing of the intestinal epithelium4 Reduce gut inflammation and restore tight junction integrity5 Modulate the vagus nerve, which connects gut function to brain and immune signaling6 For long COVID patients dealing with GI symptoms, food intolerances, or fatigue that tracks with gut dysfunction, this mechanism is directly relevant
If Semaglutide is not the right fit, we will work with you to explore other safe and effective options
Others experience the opposite
Understanding these early on will help you manage them effectively and ensure a smoother treatment journey
Specifically, the brand name Zepbound has received FDA approval as of November 2023 for this indication
This product is not offered for human or veterinary use